Biosimilars: new promise for reducing healthcare costs

• 来源期刊: 生物医学研究杂志（英文版）
• 年，卷（期）: 2014,（2）
• 页码范围: 75-77
• 页数: 3页
• 语种: 英文
• DOI: 10.7555/JBR.28.20140031

摘要

INTRODUCTION After much anticipation,approval of the first U.S.biosimilar medications may be around the corner.Biosimilars hold the promise of reducing healthcare spending by offering lower-cost alternatives to high-priced biologic drugs. Biosimilars are not generic versions of existing biologics,however.Generic medications contain an active ingredient identical to that in the reference ("brandname") product.A biosimilar may contain an active ingredient slightly different from the reference product,as long as the differences are not clinically meaningful.